Targeting inflammation as a biomarker and treatment for Alzheimer's disease [ 2017 - 2021 ]

Research Grant

[Cite as]

Brief description We are undertaking the challenge of using and developing novel animal models in parallel with studies on affected human subjects to elucidate the underlying molecular mechanisms linking the changes in inflammation to amyloid plaques, neurofibrillary tangles and cognitive decline. Understanding these mechanisms will allow us to define the biological pathways involved in the onset and progression of Alzheimer’s disease, and identify potential biomarkers and therapeutic targets.

Funding Amount $AUD 728,146.62

Funding Scheme Targeted Calls

Notes Boosting Dementia Research Leadership Fellowship

Click to explore relationships graph
Viewed: [[ro.stat.viewed]]